Trial intelligence / Profile preview

Hydromorphone oral solution for postoperative pain in pediatric patients

NCT00465647Phase 4Completed

Sponsor
Purdue Pharma
Start
Apr 2007
Primary completion
May 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, open-label trial of hydromorphone in postoperative pain, sponsored by Purdue Pharma. Started Apr 2007; status: completed.

02

Drugs

hydromorphone
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00465647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00465647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call